About the Company
We do not have any company description for Sonoma Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SNOA News
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing ...
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing ...
Startup launched by 3 UC scientists, including husband of Nobel laureate Jennifer Doudna, hires CEO
It's got a new CEO, hungry VC and University of California science behind it, including work from the husband of Nobel ...
7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024
Many investors have one or more preferred fundamental or technical indicator. These help to cut through the noise surrounding ...
MarketMasterAI’s Top 500 Stocks: April 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In January, I published MarketMasterAI’s top 500 stocks to buy ...
Global Veterinary Wound Cleansers Market Set to Surge, Reaching US$ 488.2 Million by 2033
Veterinary Wound Cleansers Market is anticipated to escalate to an impressive US$ 488.2 million by 2033 an expected CAGR of ...
AGW-Mental Wellbeing 2024 - Large-size companies
To spotlight the organizations prioritizing the mental well-being of their employees, Newsweek has partnered with data researcher Plant-A for the inaugural ranking of America's Greatest Workplaces for ...
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Shares of Marinus ...
Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement
The technologies, which were purchased through NKPH’s subsidiary, Nika Europe Ltd., have a proven market track record, as each of them satisfy an important health need of the population. The positive ...
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
Hello, and welcome to the NovaBay Pharmaceuticals fourth-quarter and full year 2023 financial results conference call. All participants will be in listen-only mode. (Operator Instructions). As a ...
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous a ...
Loading the latest forecasts...